SPOON: Sustained Program for Improving Nutrition - Guatemala

Sponsor
Inter-American Development Bank (Other)
Overall Status
Completed
CT.gov ID
NCT03399617
Collaborator
The PepsiCo Foundation (Other), FundazĂșcar (Other)
1,280
1
3
39.1
32.7

Study Details

Study Description

Brief Summary

The primary goal of this study is to assess the impact of an innovative strategy to prevent undernutrition and obesity in early childhood in children 0-24 months in Guatemala. This study is designed to evaluate the impact of promoting adequate infant an young child feeding practices and the use of SQ-LNS (Small Quantity Lipid-Based Nutrient Supplements) on the nutritional status of infants and young children. The study will be conducted in Baja Verapaz, Guatemala in conjunction with Fundazucar, Guatemala.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Micronutrient Powders
  • Behavioral: SPOON behavioral change strategy
  • Dietary Supplement: SQ-LNS
N/A

Detailed Description

SPOON Guatemala is an innovative strategy to prevent undernutrition and obesity in children aged 0-24 months living in high-poverty areas of Guatemala. SPOON focuses on improving feeding practices for infant and young children, including exclusive breastfeeding, and promote the use of home-fortification with peanut-based SQ-LNS (small quantity lipid-based nutrient supplements) through a novel behavior change strategy.

The study will recruit children between 0 and 3 months of age as well as pregnant women in the third trimester. Mothers or caregivers of eligible children will be invited to participate and a consent form obtain. Participation will start at 0-6 months and the intervention will last until children are 24 months. Participants will be randomly assigned at the community level to one of two groups: a control group and a treatment group. Participants in the control group will receive the standard services provided by their local health clinics in addition to a supply of micronutrient powders from 6-24 months of age, according to the national protocol. Participants in the treatment group will be randomly assigned at an individual level to receive two different interventions:

Treatment 1: This group will receive SQ-LNS supplement from 6-24 months and an innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

Treatment 2. This group will receive micronutrient powders from 6-24 months and an innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

A sample size of 500 children per group has been calculate to detect a minimum effect size of 0.2 with 95% level of significance and a 80% power for use of SQ-LNS. Additionally, a sample size of 40 communities and 500 children per group has been calculated to detect a minimum detectable effect size of 0.32 for communication.

Main outcomes include infant and young child feeding practices, height, weight, hemoglobin, prevalence of anemia, prevalence of stunting, prevalence of obesity, and weight gain rate. A baseline and final survey will be conducted to collect data for these variables, as well as sociodemographic information. Impact estimation will be done comparing the average results and the distribution of indicators between the treatment and control group. Differences of simple means and regression models including co-variables of the child's age and sex, and characteristics of the primary caregiver and household will be estimated. In addition to potential changes in indicator averages, changes in the distribution of variables will be explored under the hypothesis that the intervention might not only improve average value for a given indicator, but compress the distribution over a range of values closer to an optimal range. Changes to distributions will be checked by applying the Kolmogorov-Smirnov test.

Study Design

Study Type:
Interventional
Actual Enrollment :
1280 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effect of an Innovative Behavioral Change Strategy and SQ-LNS on Stunting and Obesity in Children Living in Baja Verapaz, Guatemala
Actual Study Start Date :
Sep 15, 2018
Actual Primary Completion Date :
Nov 18, 2021
Actual Study Completion Date :
Dec 18, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard Care+MNPs

Participants will receive standard health care services provided by the Ministry of Health, including micronutrient powders (MNPs). Children 6 months old will receive 1 gram of powdered micronutrients for 60 days every 6 months until 24 months of age.

Dietary Supplement: Micronutrient Powders
Micronutrient powders (5 nutrient formulation) are currently provided by the Guatemalan Ministry of Health to children between 6-24 months of age.
Other Names:
  • MNPs
  • Experimental: SPOON behavioral change strategy+SQ-LNS

    Participants will receive Small Quantity Lipid-based Supplements (SQ-LNS) from 6-24 months and a behavioral change to promote adequate infant and young child feeding practices and the use of SQ-LNS will be delivered to mothers or caregivers. The behavioral change strategy includes individual home-visits, group sessions, and community mobilization activities. SQ-LNS consists of a 20g nutrient supplement package to be consumed daily from 6-24 of age. SQ-LNS formulation does not include sugar.

    Behavioral: SPOON behavioral change strategy
    An innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

    Dietary Supplement: SQ-LNS
    SQ-LNS is a peanut-based ready to use home fortification product to improve diet quality in children 6-24 months of age. It includes peanuts and other ingredients such as vegetable fat, powdered milk and several micronutrients. The formulation designed for this study does not include sugar.
    Other Names:
  • Smal Quantity Lipid-base Nutrient Supplements
  • Experimental: SPOON behavioral change strategy+MNPs

    Participants will receive micronutrient powders (MNPs) from 6-24 months and a behavioral change to promote adequate infant and young child feeding practices and the use of MNPs will be delivered to mothers or caregivers. The behavioral change strategy includes individual home-visits, group sessions, and community mobilization activities.

    Dietary Supplement: Micronutrient Powders
    Micronutrient powders (5 nutrient formulation) are currently provided by the Guatemalan Ministry of Health to children between 6-24 months of age.
    Other Names:
  • MNPs
  • Behavioral: SPOON behavioral change strategy
    An innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

    Outcome Measures

    Primary Outcome Measures

    1. Infant and young child feeding practices [Measured at baseline and after 24 months of intervention]

      Set of indicators of infant and young child feeding practices obtained by interview to participant mothers or caregivers

    2. Height [Measured at 6 and 24 months of age]

      Height-for-age z score obtained by measuring the height of participant children

    3. Weight gain rate [Constructed from weight measurements at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 months of age]

      Rate of weight gain from 0-24 months of age

    4. Hemoglobin [Measured at 6 and 24 months of age]

      Measurement of hemoglobin using a portable photometer

    5. Prevalence of obesity in children [Measured at 6 and 24 months of age]

      Population estimation of obesity using Population estimation of obesity using Body Mass Index (BMI)

    6. Prevalence of stunting [Measured at 6 and 24 months of age]

      Population estimation of stunting using height-for age <-2 SD

    7. Prevalence of anemia [Measured at 6 and 24 months of age]

      Population estimation of anemia using hemoglobin

    Secondary Outcome Measures

    1. Adherence to Nutritional Supplement Regime [Measured every months from 6 months of age until the end of the intervention]

      Consumption of the nutritional supplement measured as the number of packets consumed in one month

    2. Exclusive Breastfeeding [Measured 24 months after the start of the intervention]

      Measured as an indicator of exclusive breastfeeding, self-reported by the mother of a child

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 3 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Pregnant women in the third trimester or children 3 months of age

    • Living in the defined intervention areas

    • Children with no chronic diseases or congenital malformations

    • Not planning on moving far from the intervention area in the next 24 months

    Exclusion Criteria:
    • Children with any chronic disease or congenital malformation

    • Caretakers of the children plan on moving in the next 24 months

    • Children with severe acute malnutrition

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 SPOON Guatemala Rabinal Baja Verapaz Guatemala

    Sponsors and Collaborators

    • Inter-American Development Bank
    • The PepsiCo Foundation
    • FundazĂșcar

    Investigators

    • Study Director: Sebastian Martinez, IDB Evaluation Specialist

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Inter-American Development Bank
    ClinicalTrials.gov Identifier:
    NCT03399617
    Other Study ID Numbers:
    • Inter-AmericanDB Guatemala
    First Posted:
    Jan 16, 2018
    Last Update Posted:
    Mar 9, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Inter-American Development Bank
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 9, 2022